Narrow Results

This paper showcases a low-power demodulator for medical implant communication services (MICS) applications. Complementary shunt resistive feedback, current reuse configuration, and sub-threshold LO driving techniques are proposed to achieve ultra-low power consumption. The chip has been implemented in standard CMOS process and consumes only 260-$\mu$W.

Young Innovators under 35 - 2016 Asia's TR35 Innovators (EmTech Asia 2016)

New Biomedical R&D Centre Set Up by Lite-On Group in Singapore

The Philippines Initiates the World's First Public Dengue Vaccination Programme

SINGAPORE – A New Way of Looking at Cancer

SINGAPORE – Novel Discovery by NUS Scientists Improves Profiling of AML Patients for Targeted Therapies

SINGAPORE – Red Meat Consumption Linked with Increased Risk of Developing Kidney Failure

SINGAPORE – Thomson Medical and UK-based Cell Therapy Limited Collaborate on Stem Cell Research to Develop Regenerative Medicines

UNITED STATES – New Biomaterial Developed for Injectable Neuronal Control

UNITED STATES – Research Shines Light on Lesser Known Form of Vitamin D in Foods

UNITED STATES – MRIGlobal to Lead International Research Collaboration for Tularemia Vaccine

INDIA – Improving Agricultural Yield and Quality through Tissue Culture Technology

TAIWAN – A Cascade of Protein Aggregation Bombards Mitochondria for Neurodegeneration and Apoptosis under WWOX Deficiency

Geoffrey Ball and his Innovation: VIBRANT SOUNDBRIDGE Hearing Implant.

Interviews with Nobel Laureates in Physiology or Medicine.

Talk about Over-the-Counter (OTC) Medicines and Self-Care.

The objective of this study was to establish an ovine model for CH-VAD (CH Biomedical Inc., JiangSu, China) implantable ventricular assist device (IVAD) to evaluate experimental protocols, including anesthesia management, surgical process, autopsy criteria and a validated anticoagulation procedure. Method: IVAD was implanted into the chest of sheep without stopping the beating heart through a left thoracotomy, and the inflow cannula was connected to the left ventricular apex and the outflow cannula was anastomosed to the descending aorta. Results: Totally 23 cases were established: 6 died of an anaesthetic or surgical reasons, one died of lung infection, the other 16 cases survived for more than 15 days, among which four cases were terminated because of decrease of pump flow and the other 12 cases survived for more than 30 days. Conclusions: Sheep models suitable for implantation of CH-VAD implantable LVAD were successfully established and the appropriate safety evaluation indicators of this model were validated in the course of the animal experiments, and the survival rate of the experiments were improved gradually over time.

Recent advances in miniaturized nano-based devices are rapidly extending the boundaries of biomedical technologies, particularly biosensors. Highly selective biosensors with the ability to simultaneously detect multiple targets were developed in recent years. The most eye-catching classifications of such biosensors coupled with the emergence of stimuli-responsive and CRISPR/Cas-sensitive systems. Furthermore, attractive features of wearable and implantable biosensors have led to the design of portable, remote controllable diagnostic systems for tackling healthcare challenges in every part of the world, especially in places with limited access to clinical resources. Nevertheless, there are still some barriers to widespread applications of biosensors due mainly to their high costs and the lack of a single biosensing device for highly selective targeting of multiple analytes. Herein, we review the latest developments in biomedical technologies with a focus on biosensors including smart stimuli-responsive, CRISPR/Cas-sensitive, wearable, and implantable biosensors to spark innovations in this field.